tenk.fyi

X4 Pharmaceuticals, Inc

XFORNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$35.1M

1273.2% YoY

Net Income

-$79.2M

111.5% YoY

EPS

$-1.87

66.5% YoY

Cash

$217.0M

289.7% YoY

FY 2025 · As of 2025-12-31